Methoxsalen | 8-Methoxypsoralen;Xanthotoxin;Oxsorale;Methoxypsoralen. NCI-C55903;8-MOP | 甲氧沙林 | Other Compounds | P450

首页 / / / / Methoxsalen

花椒毒素 /Methoxsalen {[allProObj[0].p_purity_real_show]}

货号：A372661 同义名： 甲氧沙林 / 8-Methoxypsoralen;Xanthotoxin

Methoxsalen is a furanocoumarin and an active compound of a traditional Egyptian medicinal plant Ammi majus L, whose juice/fruit has been used for many years in folk phototherapy for the treatment of vitiligo or a hyperproliferative skin disorder, psoriasis. It is a potent suicide inhibitor of CYP (cytochrome P-450), is an agent used to treat psoriasis, eczema, vitiligo and some cutaneous Lymphomas in conjunction with exposing the skin to sunlight.

Methoxsalen 化学结构
CAS号：298-81-7

Methoxsalen 3D分子结构
CAS号：298-81-7

规格	价格	会员价	库存	数量
{[ item.pr_size ]}	{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]}	{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]}	{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]}	{[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]}	现货	咨询	- +

购物车0 收藏询单

sales@ambeed.cn tech@ambeed.cn 400-920-2911 产品手册产品订购技术咨询
快速发货顺丰冷链运输，1-2 天到达

品质保证

技术支持

免费溶解

Methoxsalen 纯度/质量文件产品仅供科研

货号：A372661 标准纯度： {[allProObj[0].p_purity_real_show]} 产品说明书

批次查询：批次纯度: COA SDS NMR HPLC CNMR LC-MS

全球学术期刊中引用的产品: • Nat. Biomed. Eng., 2024, 8, 1412-1424. Ambeed. [ A538667 , A631746 ]; • JMC, 2024. Ambeed. [ A833302 , A475501 , A341986 , A356070 ]; • BMC Cancer, 2024, 24(1): 1415. Ambeed. [ A809692 , A209020 ]; • J. Am. Soc. Mass Spectrom., 2024, 35(12): 3192-3202. Ambeed. [ A166127 , A902473 , A753371 , A961334 , A292945 , A230770 , A300620 , A1114580 , A1159765 , A206238 ]; • PloS One, 2024, 19(11): e0308060. Ambeed. [ A302917 ]; 更多 >

Methoxsalen 生物活性

描述

Methoxsalen is a potent tricyclic furocoumarin suicide inhibitor of CYP (cytochrome P-450), is an agent used to treat psoriasis, eczema, vitiligo and some cutaneous Lymphomas in conjunction with exposing the skin to sunlight. Methoxsalen modifies the way skin cells receive the UVA radiation, allegedly clearing up the disease. Methoxsalen pretreatment prolonged the duration of nicotine-induced antinociception and hypothermia (15mg/kg, po) for periods up to 6- and 24-hr postnicotine administration, respectively^[3]. Using the guinea pig as an experimental model, UV-A (long-wave UV) irradiation given immediately after the topical application of methoxsalen resulted in the notable suppression of tritiated thymidine incorporation into epidermal basal cells^[4]. Oral methoxsalen when used in the higher dose followed by sun exposure is an effective treatment for psoriasis^[5]. Administration of methoxsalen (50 mumol X kg-1 i.p.) increased 4-fold the hexobarbital sleeping time in rats. Methoxsalen (25-1000 microM) decreased cytochrome P-450 in vitro, in the presence of EDTA; this effect required NADPH and oxygen, was decreased by piperonyl butoxide and was increased by phenobarbital pretreatment. Similarly, administration of methoxsalen (125 mumol X kg-1 i.p.) decreased cytochrome P-450 and monooxygenase activities in vivo; the decrease in cytochrome P-450 was enhanced by phenobarbital pretreatment and was prevented by piperonyl butoxide^[6].

Methoxsalen 临床研究

NCT号	适应症或疾病	临床期	招募状态	预计完成时间	地点
NCT00045305	-		Completed	-	-
NCT00724061	Lymphoma	Not Applicable	Terminated(Closed early due to... 展开 >> poor accrual.) 收起 <<	-	United States, Illinois ... 展开 >> Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States, 60611-3013 收起 <<
NCT00045305	Leukemia Myel... 展开 >>odysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms 收起 <<	Phase 2	Completed	-	United States, Arizona ... 展开 >> Mayo Clinic Scottsdale Scottsdale, Arizona, United States, 85259-5499 United States, Florida Mayo Clinic - Jacksonville Jacksonville, Florida, United States, 32224 United States, Massachusetts Tufts-NEMC Cancer Center Boston, Massachusetts, United States, 02111 United States, Minnesota Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 United States, Ohio Jewish Hospital Cancer Center Cincinnati, Ohio, United States, 45236 United States, Pennsylvania Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104-4283 收起 <<

Methoxsalen 参考文献

[1]Zhang W, Kilicarslan T, et al. Evaluation of methoxsalen, tranylcypromine, and tryptamine as specific and selective CYP2A6 inhibitors in vitro. Drug Metab Dispos. 2001 Jun;29(6):897-902.

[2]Maenpaa J, Juvonen R, et al Metabolic interactions of methoxsalen and coumarin in humans and mice. Biochem Pharmacol. 1994 Oct 7;48(7):1363-9.

[3]Alsharari SD, Siu EC, Tyndale RF, Damaj MI. Pharmacokinetic and pharmacodynamics studies of nicotine after oral administration in mice: effects of methoxsalen, a CYP2A5/6 inhibitor. Nicotine Tob Res. 2014 Jan;16(1):18-25

[4]Danno K, Toda K, Ishida H, Horio T. Topical methoxsalen followed immediately by long-wave UV irradiation. A preliminary report on the treatment of psoriasis. Arch Dermatol. 1982 Jul;118(7):471-3

[5]Parrish JA, White AD, Kingsbury T, Zahar M, Fitzpatrick TB. Photochemotherapy of psoriasis using methoxsalen and sunlight. A controlled study. Arch Dermatol. 1977 Nov;113(11):1529-32

[6]Fouin-Fortunet H, Tinel M, Descatoire V, Letteron P, Larrey D, Geneve J, Pessayre D. Inactivation of cytochrome P-450 by the drug methoxsalen. J Pharmacol Exp Ther. 1986 Jan;236(1):237-47

Methoxsalen 实验方案

计算器

存储液制备

1mg

5mg

10mg

1 mM

5 mM

10 mM

4.63mL

0.93mL

0.46mL

23.13mL

4.63mL

2.31mL

46.26mL

9.25mL

4.63mL

Methoxsalen 技术信息

CAS号	298-81-7
分子式	C₁₂H₈O₄
分子量	216.19

别名	甲氧沙林 ;8-Methoxypsoralen;Xanthotoxin;Oxsorale;Methoxypsoralen. US brand names: Ammoidin;NCI-C55903;8-MOP
运输	蓝冰

存储条件

液体 -20°C:3-6个月-80°C:12个月

粉末 Sealed in dry,Room Temperature

溶解度

DMSO: 50 mg/mL(231.28 mM)，配合低频超声，并水浴加热至45℃助溶，注意：DMSO长时间开封后，会吸水并导致溶解能力下降，请避免使用长期开封的DMSO

动物实验配方

临床研究

NCT号	适应症或疾病	临床期	招募状态	预计完成时间	地点

NCT00045305	-		Completed	-	-
NCT00724061	Lymphoma	Not Applicable	Terminated(Closed early due to... 展开 >> poor accrual.) 收起 <<	-	United States, Illinois ... 展开 >> Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States, 60611-3013 收起 <<
NCT00045305	Leukemia Myel... 展开 >>odysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms 收起 <<	Phase 2	Completed	-	United States, Arizona ... 展开 >> Mayo Clinic Scottsdale Scottsdale, Arizona, United States, 85259-5499 United States, Florida Mayo Clinic - Jacksonville Jacksonville, Florida, United States, 32224 United States, Massachusetts Tufts-NEMC Cancer Center Boston, Massachusetts, United States, 02111 United States, Minnesota Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 United States, Ohio Jewish Hospital Cancer Center Cincinnati, Ohio, United States, 45236 United States, Pennsylvania Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104-4283 收起 <<
NCT01402414	Atopic Dermatitis	Not Applicable	Terminated(Difficulties with t... 展开 >>he Recruitement) 收起 <<	-	Germany ... 展开 >> Department of Dermatology, Ruhr University Bochum Bochum, NRW, Germany, 44791 收起 <<
NCT00005092	Leukemia Lymp... 展开 >>homa Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes 收起 <<	Phase 1	Completed	-	United States, Illinois ... 展开 >> University of Illinois at Chicago Chicago, Illinois, United States, 60612 United States, Missouri Washington University Barnard Cancer Center Saint Louis, Missouri, United States, 63110 United States, Texas University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030-4009 收起 <<
NCT01824368	Liver Transplantation ... 展开 >> Immunosuppression 收起 <<	Phase 1 Phase 2	Completed	-	Spain ... 展开 >> University Hospital Virgen de la Arrixaca El Palmar, Murcia, Spain, 30120 收起 <<
NCT02296346	Secondary Progressive Multiple... 展开 >> Sclerosis 收起 <<	Phase 1	Suspended(PI Changed sites and... 展开 >> we are waiting to open it at the new site.) 收起 <<	-	United States, Michigan ... 展开 >> University of Michigan Health Systems Ann Arbor, Michigan, United States, 48109 收起 <<
NCT00724061	-		Terminated(Closed early due to... 展开 >> poor accrual.) 收起 <<	-	-
NCT03083574	Refractory Chronic Graft Versu... 展开 >>s Host Disease (cGVHD) 收起 <<	Phase 2	Recruiting	September 2023	Belgium ... 展开 >> Ziekenhuis Netwerk Antwerpen Recruiting Antwerpen, Belgium, 2060 Contact: Pierre Zachee, MD, PhD 32-3-2177111 pierre.zachee@zna.be Principal Investigator: Pierre Zachee, MD, PhD AZ Sint-Jan Brugge Recruiting Brugge, Belgium, 8000 Contact: Dominik Selleslag, MD 32-50-453060 dominik.selleslag@azbrugge.be Contact: Tom Lodewyck, MD 32-50-453060 tom.lodewyck@azbrugge.be Principal Investigator: Dominik Selleslag, MD Sub-Investigator: Tom Lodewyck, MD Institut Jules Bordet Recruiting Brussels, Belgium, 1000 Contact: Philippe Lewalle, MD, PhD 32-2-5417208 philippe.lewalle@bordet.be Principal Investigator: Philippe Lewalle, MD, PhD Universitair Ziekenhuis Antwerpen Recruiting Edegem, Belgium, 2650 Contact: Zwi Berneman, MD, PhD 32-3-2204111 zwi.berneman@uza.be Principal Investigator: Zwi Berneman, MD, PhD Universitair Ziekenhuis Gent Not yet recruiting Gent, Belgium, 8000 Contact: Lucien Noens, MD, PhD 32-9-3323464 Lucien.Noens@Ugent.be Contact: Tessa Kerre, MD, PhD 32-9-3323464 Tessa.Kerre@Ugent.be Principal Investigator: Tessa Kerre, MD, PhD Sub-Investigator: Lucien Noens, MD, PhD Universitair Ziekenhuis Brussel Recruiting Jette, Belgium, 1090 Contact: Rik Schots, MD, PhD 32-2-4763105 Rik.Schots@uzbrussel.be Contact: Ann De Becker, MD 32-2-4763105 Ann.Debecker@uzbrussel.be Principal Investigator: Rik Schots, MD, PhD Sub-Investigator: Ann De Becker, MD CHU Liège Recruiting Liège, Belgium, 4000 Contact: Yves Beguin, MD, PhD 32-4-3667201 yves.beguin@chu.ulg.ac.be Contact: Frédéric Baron, MD, PhD 32-4-3667201 F.Baron@ulg.ac.be Principal Investigator: Yves Beguin, MD, PhD Sub-Investigator: Frederic Baron, MD, PhD Sub-Investigator: Evelyne Willems, MD Cliniques Universitaires Saint-Luc Recruiting Woluwe-Saint-Lambert, Belgium, 1200 Contact: Xavier Poiré, MD 32-2-7641809 Xavier.Poire@uclouvain.be Principal Investigator: Xavier Poiré, MD 收起 <<
NCT00265603	Non-Small Cell Lung Cancer	Phase 1	Terminated	-	United States, New Jersey ... 展开 >> Morristown Memorial Hospital Morristown, New Jersey, United States, 07962-1956 收起 <<
NCT00179855	Graft Versus Host Disease ... 展开 >> Cancer Stem Cell Transplantation 收起 <<	Phase 2 Phase 3	Unknown	July 2012	United States, Illinois ... 展开 >> Children's Memorial Hospital Recruiting Chicago, Illinois, United States, 60614 Contact: Morris Kletzel, MD 773-880-4562 MKletzel@childrensmemorial.org 收起 <<
NCT01460914	-		Active, not recruiting	October 2050	United States, New Hampshire ... 展开 >> Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States, 03756 收起 <<
NCT02631993	-		Completed	-	Sweden ... 展开 >> Department of Dermatology, Karolinska University Hospital Huddinge Stockholm, Sweden, 14186 收起 <<
NCT01559584	Alopecia Areata	Not Applicable	Completed	-	Egypt ... 展开 >> Dermatology department - faculty of medicine- Cairo University Cairo, Egypt 收起 <<
NCT02090621	Hepatic Insufficiency	Phase 2	Completed	-	Spain ... 展开 >> Jose Antonio Pons, MD Murcia, El Palmar, Spain, 30120 收起 <<
NCT00402714	Hematologic Malignancies	Phase 2	Completed	-	United States, Connecticut ... 展开 >> Yale Comprehensive Cancer Center at Yale University School of Medicine New Haven, Connecticut, United States, 06520 United States, Massachusetts Tufts-New England Medical Center Boston, Massachusetts, United States, 02111 United States, Texas Methodist Hospital - Texas Transplant Institute San Antonio, Texas, United States, 78229 收起 <<
NCT00157001	Stable Angina Pectoris ... 展开 >> Unstable Angina Pectoris Silent Ischemia 收起 <<	Phase 2	Terminated	-	United States, New Jersey ... 展开 >> Morristown Memorial Hospital Morristown, New Jersey, United States, 07962-1956 收起 <<
NCT00402714	-		Completed	-	-
NCT03361254	Graft Versus Host Disease	Not Applicable	Not yet recruiting	September 30, 2018	-
NCT03204721	Graft-Versus-Host Disease	Not Applicable	Recruiting	December 31, 2020	Norway ... 展开 >> Tobias Gedde-Dhl Recruiting Oslo, Norway Contact: Tobias Gedde-Dahl, MD, PhD +47 915 20 292 tgeddeda@ous-hf.no Contact: Maryan M Ali, MD +47 995 52 805 maryan0007@hotmail.com 收起 <<
NCT03109353	Cutaneous T-Cell Lymphoma, Uns... 展开 >>pecified Chronic Graft Versus Host Disease in Skin 收起 <<	Phase 1 Phase 2	Recruiting	September 2020	Norway ... 展开 >> St Olavs Hospital Recruiting Trondheim, Norway Contact: Eidi Christensen, md phd eidi.christensen@ntnu.no 收起 <<
NCT02796898	Prostate Cancer ... 展开 >> Rising Prostate Specific Antigen (PSA) 收起 <<	Phase 1 Phase 2	Recruiting	December 31, 2019	United States, New Jersey ... 展开 >> AdvanceMed Research Completed Lawrence, New Jersey, United States, 08648 United States, New York Montefiore Medical Center- Montefiore Medical Park Not yet recruiting Bronx, New York, United States, 10461 Contact: Gartrell Benjamin, MD 718-405-8404 bgartrel@montefiore.org Eastchester Center for Cancer Care Recruiting Bronx, New York, United States, 10469 Contact: Carmen Vicuna 718-732-4078 cvicuna@nycancer.com AccuMed Research Associates Recruiting Garden City, New York, United States, 11530-1664 Contact: Tammi Allegra, RN 516-746-2190 tallegra.accumedresearch@gmail.com United States, Pennsylvania MidLantic Urology Recruiting Bala-Cynwyd, Pennsylvania, United States, 19004 Contact: Cheryl A Zinar, RN, BSN 610-667-0458 Principal Investigator: Laurence H Belkoff, DO 收起 <<
NCT00639717	-		Completed	-	-
NCT00030589	Lymphoma	Phase 2	Unknown	-	United States, Alabama ... 展开 >> University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States, 35294-3300 United States, Arkansas University of Arkansas for Medical Sciences Little Rock, Arkansas, United States, 72205 United States, California Stanford University Medical Center Stanford, California, United States, 94305 United States, Colorado University of Colorado Health Science Center Aurora, Colorado, United States, 80010-0510 United States, Florida H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612-9497 United States, Illinois Northwestern University Medical Center Chicago, Illinois, United States, 60611 Rush-Presbyterian-St. Luke's Medical Center Chicago, Illinois, United States, 60612 United States, Louisiana Tulane University School of Medicine New Orleans, Louisiana, United States, 70112 Slidell, Louisiana, United States, 70459-0059 United States, Massachusetts Boston Medical Center Boston, Massachusetts, United States, 02118-2393 United States, Michigan Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201-1379 Henry Ford Hospital Detroit, Michigan, United States, 48202 United States, New York StonyBrook Dermatology Associates, P.C. East Setauket, New York, United States, 11733 St. Luke's-Roosevelt Hospital Center - Roosevelt Division New York, New York, United States, 10019 United States, Ohio Ireland Cancer Center Cleveland, Ohio, United States, 44106-5065 United States, Tennessee Knoxville Dermatology Group, P.C. Knoxville, Tennessee, United States, 37920 United States, Texas Simmons Cancer Center - Dallas Dallas, Texas, United States, 75235-9154 University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030-4009 Tyler, Texas, United States, 75703 收起 <<
NCT03605940	Acute-graft-versus-host Diseas... 展开 >>e 收起 <<	Phase 2	Not yet recruiting	April 1, 2022	-
NCT00004359	Epidermolysis Bullosa Acquisit... 展开 >>a 收起 <<	Phase 2	Completed	-	-
NCT00639717	Graft Versus Host Disease	Phase 2	Completed	-	United States, Michigan ... 展开 >> University of Michigan Cancer Center Ann Arbor, Michigan, United States, 48109 收起 <<
NCT03512756	Pancreatic Cancer	Phase 2	Recruiting	December 31, 2019	-
NCT00056355	Crohn Disease	Phase 1	Completed	-	United States, Maryland ... 展开 >> National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States, 20892 收起 <<
NCT00630903	Cutaneous T-Cell Lymphoma (Myc... 展开 >>osis Fungoides) 收起 <<	Phase 4	Terminated(Insufficient accrua... 展开 >>l) 收起 <<	-	Spain ... 展开 >> Hospital Príncipe de Asturias. Alcalá de Henares, Madrid, Spain Hospital Universitario de Getafe Getafe, Madrid, Spain Hospital de la Princess Madrid, Spain, 28009 Hospital Universitario 12 de Octubre Madrid, Spain, 28041 Fundación Jiménez Díaz Madrid, Spain Hospital Clínico San Carlos Madrid, Spain Hospital Gómez Ulla Madrid, Spain Hospital La Paz Madrid, Spain Hospital Ramón y Cajal Madrid, Spain 收起 <<
NCT02322190	Chronic Graft vs. Host Disease... 展开 >> Graft vs Host Disease Graft-Versus-Host Disease 收起 <<	Phase 2	Suspended	October 1, 2027	United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 <<
NCT00002011	HIV Infections	Not Applicable	Completed	-	United States, New Jersey ... 展开 >> Morristown Memorial Hosp Morristown, New Jersey, United States, 07962 收起 <<
NCT02181257	-		Active, not recruiting	December 2018	United States, Alabama ... 展开 >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35226 United States, California University of California San Diego La Jolla, California, United States, 92093 United States, Indiana Indiana University Health Indianapolis, Indiana, United States, 46202 United States, Iowa University of Iowa Iowa City, Iowa, United States, 52242 United States, Michigan University of Michigan Health System Ann Arbor, Michigan, United States, 48109 United States, Minnesota University of Minnesota Medical Center, Fairview Minneapolis, Minnesota, United States, 55455 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, New York Columbia University New York, New York, United States, 10032 United States, Ohio The Cleveland Clinic Cleveland, Ohio, United States, 44195 United States, Pennsylvania University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 收起 <<
NCT00054613	Graft-versus-Host Disease	Phase 2	Completed	-	-
NCT01174940	Stem Cell Leukemia of Unclear ... 展开 >>Lineage Graft Versus Host Disease 收起 <<	Early Phase 1	Completed	-	United States, Kansas ... 展开 >> University of Kansas Medical Center Kansas City, Kansas, United States, 66160 收起 <<
NCT00533195	Atopic Dermatitis	Phase 3	Completed	-	Austria ... 展开 >> Medical University of Vienna; University Clinic of Dermatology; Division of Special and Environmental Dermatology Vienna, Austria, 1090 收起 <<
NCT00056056	Lymphoma	Phase 3	Terminated(poor accrual)	-	-
NCT00221000	Rheumatoid Arthritis	Phase 2	Completed	-	-
NCT00930566	Hematological Malignancies	Phase 1 Phase 2	Unknown	September 2015	France ... 展开 >> Centre de Santé - Etablissement Français du Sang (EFS) Active, not recruiting Lyon, France, 69003 Hôpital Edouard Herriot, Service d'Hématologie Recruiting Lyon, France, 69003 Contact: Aline Praire +33472117396 aline.praire@chu-lyon.fr Principal Investigator: Mauricette Michallet, Professor 收起 <<
NCT00157027	HIV Infections	Phase 1	Withdrawn	April 2010	-
NCT01686594	Patch/Plaque Stage Mycosis Fun... 展开 >>goides 收起 <<	Phase 3	Completed	-	Austria ... 展开 >> Medical University of Graz Graz, Austria, 8010 Department of Dermatology, Medical University of Innsbruck Innsbruck, Austria, A-6020 Department of Dermatology, General Hospital of the City of Linz Linz, Austria, A-4021 Department of Dermatology, Hospital Salzburg - Paracelsus Private Medical University Salzburg, Austria, A-5020 Department of Dermatology, County Hospital St. Pölten St. Pölten, Austria, A-3100 Department of Dermatology, Medical University of Vienna Vienna, Austria, A-1090 Department of Dermatology, Hospital Hietzing Vienna, Austria, A-1130 Department of Dermatology, Klinikum Wels Wels, Austria, A-4600 Department of Dermatology, County Hospital Wiener Neustadt Wiener Neustadt, Austria, A-2700 收起 <<
NCT00282503	Acute Graft-versus-Host Diseas... 展开 >>e 收起 <<	Phase 3	Terminated(Lack of recruitment... 展开 >>) 收起 <<	-	-
NCT01380535	Chronic Graft Versus Host Dise... 展开 >>ase 收起 <<	Phase 1	Completed	-	-
NCT00811005	Pustular Palmoplantar Psoriasi... 展开 >>s 收起 <<	Phase 3	Unknown	October 2010	Austria ... 展开 >> Medical University of Vienna; University Clinic of Dermatology; Division of Special and Environmental Dermatology Vienna, Austria, 1180 收起 <<
NCT03563040	Lymphoma, T-Cell, Cutaneous ... 展开 >> Mycosis Fungoides/Sezary Syndrome 收起 <<	Phase 2	Not yet recruiting	June 1, 2025	Switzerland ... 展开 >> UniversitaetsSpital Zurich - Division of Dermatology Not yet recruiting Zürich, Switzerland Principal Investigator: Emmanuella Guenova 收起 <<
NCT00054600	Graft-versus-Host Disease	Phase 2	Completed	-	United States, Florida ... 展开 >> University of Florida Gainesville, Florida, United States, 32611 United States, Illinois University of Chicago Chicago, Illinois, United States, 60637 United States, Massachusetts Tufts New England Medical Center Boston, Massachusetts, United States, 02111 United States, Missouri Kansas City Cancer Center Kansas City, Missouri, United States, 64111 United States, Ohio Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 United States, Texas Texas Transplant San Antonio, Texas, United States, 78229 Australia Royal Brisbane Hospital Brisbane, Australia, 4006 Peter MacCallum Cancer Institute East Melbourne, Australia, 8006 Alfred Hospital Melbourne, Australia Royal Melbourne Hospital Parkville, Australia, 3050 St. Vincent's Hospital Sydney, Australia, 2010 Brazil Hospital Azevedo Carvalho Jau, Brazil National Cancer Institute Rio de Janeiro, Brazil Hemocentro Sao Paulo, Brazil Germany Ludwig-Maximiliano Universitaet Muenchen Munchen, Germany, D-81377 Italy Careggi Hospital Florence, Italy, 1-50134 San Martino Hospital Genova, Italy, 16132 Portugal Instituto Portugues de Oncologia de Francisco Gentil Lisbon, Portugal, 1099-023 Slovakia National Cancer Institute Bratislava, Slovakia Turkey Ankara University Medical School Ankara, Turkey, 6100 United Kingdom Hammersmith Hospital London, United Kingdom, W12 0NN 收起 <<
NCT00221026	Crohn's Disease	Phase 2	Completed	-	United States, Maryland ... 展开 >> NIH Bethesda, Maryland, United States Metropolitian Gastroenterology Group Chevy Chase, Maryland, United States United States, New Jersey Morristown Memorial Hospital Morristown, New Jersey, United States United States, New York Mount Sinai Medical Center New York, New York, United States Austria General Hospital of Vienna Vienna, Austria Belgium Hospital Erasme/ULB Brussels, Belgium UZ Leuven Leuven, Belgium Germany Universitat St Josef Bochum, Germany Krankenhaus Duren gem.GmbH Duren, Germany Universitatsklinik Essen Essen, Germany Universitatsklinikum Jena, Germany Universitatsklinikum Mannheim Mannheim, Germany University Hospital Munich-Grosshadem Munich, Germany Klinikum Oldenberg Oldenburg, Germany Medizinische Universitatsklinik Ulm Ulm, Germany 收起 <<
NCT02524847	Steroid Refractory Acute Graft... 展开 >> Versus Host Disease 收起 <<	Phase 3	Recruiting	January 2022	-
NCT00221039	Cutaneous T Cell Lymphoma ... 展开 >> Mycosis Fungoides 收起 <<	Phase 4	Completed	-	United States, Illinois ... 展开 >> Rush-Presbyterian Hospital Chicago, Illinois, United States, 60612 United States, Massachusetts Boston Medical Center Boston, Massachusetts, United States, 02118 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, Ohio University Hospital of Cleveland/Case Western Reserve University Cleveland, Ohio, United States, 44106 United States, Pennsylvania University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 United States, Tennessee Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 <<

花椒毒素 /Methoxsalen {[allProObj[0].p_purity_real_show]}

Methoxsalen 纯度/质量文件产品仅供科研

全球学术期刊中引用的产品

Methoxsalen 质控信息

Methoxsalen 生物活性

Methoxsalen 临床研究

Methoxsalen 参考文献

Methoxsalen 实验方案

Methoxsalen 技术信息

最近浏览的产品

大规格询价

摩尔计算器

靶点

总药量计算器

工作液计算器

细胞研究

临床研究

确认信息

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

花椒毒素 /Methoxsalen {[allProObj[0].p_purity_real_show]}

Methoxsalen 纯度/质量文件 产品仅供科研

全球学术期刊中引用的产品

Methoxsalen 质控信息

Methoxsalen 生物活性

Methoxsalen 临床研究

Methoxsalen 参考文献

Methoxsalen 实验方案

Methoxsalen 技术信息

最近浏览的产品

大规格询价

摩尔计算器

靶点

总药量计算器

工作液计算器

细胞研究

临床研究

确认信息

请登录您的专属账户

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

Methoxsalen 纯度/质量文件产品仅供科研